Investor Relations

Webcast
Q2 2019 Nuvectra Earnings Conference Call
Wednesday, July 31, 2019 04:30 PM EDT

CORPORATE PROFILE

Nuvectra® is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS).

On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas with additional locations in Denver and Minneapolis.

Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR." Nuvectra

STOCK QUOTE

(Common Stock)   
Exchange
Volume
Today's Open
Previous Close
Data as of  

Copyright West LLC. Minimum 15 minutes delayed.

Events
Date Title
Wednesday, July 31, 2019 04:30 PM EDT

STOCK CHART

INVESTOR CONTACT

The Ruth Group
Tram Bui
investors@nuvectramed.com